Talk:MAGEA4
 | This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||
| ||||||||||||||
Recently a CAR-T cell therapy (TECELRA, Adaptimmune LLC) targeting MAGE-A4 protein expressed by synovial sarcoma has received approval by the FDA.
[edit]Recently a CAR-T cell therapy (TECELRA, Adaptimmune LLC) targeting MAGE-A4 protein expressed by synovial sarcoma has received approval by the FDA.